GR3020044T3 - Vaccines against equine herpes viruses and their preparation - Google Patents

Vaccines against equine herpes viruses and their preparation

Info

Publication number
GR3020044T3
GR3020044T3 GR960401407T GR960401407T GR3020044T3 GR 3020044 T3 GR3020044 T3 GR 3020044T3 GR 960401407 T GR960401407 T GR 960401407T GR 960401407 T GR960401407 T GR 960401407T GR 3020044 T3 GR3020044 T3 GR 3020044T3
Authority
GR
Greece
Prior art keywords
preparation
vaccines against
herpes viruses
equine herpes
against equine
Prior art date
Application number
GR960401407T
Other languages
English (en)
Inventor
Peter Prof Dr Dr Habil Thein
Walter Dr Strube
Ernst Boettcher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6416744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3020044(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR3020044T3 publication Critical patent/GR3020044T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR960401407T 1990-10-20 1996-05-27 Vaccines against equine herpes viruses and their preparation GR3020044T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4033446A DE4033446A1 (de) 1990-10-20 1990-10-20 Impfstoffe gegen equine herpesviren und ihre herstellung

Publications (1)

Publication Number Publication Date
GR3020044T3 true GR3020044T3 (en) 1996-08-31

Family

ID=6416744

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401407T GR3020044T3 (en) 1990-10-20 1996-05-27 Vaccines against equine herpes viruses and their preparation

Country Status (9)

Country Link
EP (1) EP0491125B2 (el)
JP (1) JPH05247099A (el)
AT (1) ATE136790T1 (el)
AU (1) AU649728B2 (el)
CA (1) CA2053829C (el)
DE (2) DE4033446A1 (el)
DK (1) DK0491125T4 (el)
ES (1) ES2087199T5 (el)
GR (1) GR3020044T3 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667104B2 (en) * 1992-06-01 1996-03-07 University Of Melbourne, The Equine herpesvirus glycoproteins
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
EP0978286A1 (en) * 1998-08-07 2000-02-09 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
ITMI20010571A1 (it) * 2001-03-19 2002-09-19 Grisotech S A Vaccini assorbibili per via trans-mucosale
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
WO1990001546A1 (en) * 1988-08-05 1990-02-22 Applied Biotechnology, Inc. Equine herpesvirus-1 vaccine

Also Published As

Publication number Publication date
CA2053829C (en) 2001-12-04
EP0491125B1 (de) 1996-04-17
ES2087199T5 (es) 2002-03-16
AU649728B2 (en) 1994-06-02
DE59107688D1 (de) 1996-05-23
JPH05247099A (ja) 1993-09-24
DE4033446A1 (de) 1992-04-23
ES2087199T3 (es) 1996-07-16
EP0491125A1 (de) 1992-06-24
DK0491125T4 (da) 2002-01-28
DK0491125T3 (da) 1996-08-05
ATE136790T1 (de) 1996-05-15
EP0491125B2 (de) 2001-10-24
AU8599191A (en) 1992-04-30
CA2053829A1 (en) 1992-04-21

Similar Documents

Publication Publication Date Title
IL107081A0 (en) Azaquinoxalines,processes for their preparation and their use
ZA904915B (en) Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines
GR3030834T3 (en) Herpes simplex virus vp16 vaccines
IT1116480B (it) Perfezionamento nei dispositivi di fissaggio regolabile in altezza per cinture di sicurezza su autoveicoli
IT1197751B (it) Perfezionamento nei rasoi di sicurezza
DE69129207D1 (de) Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
IT8220162A0 (it) Appoggia-gambe, specialmente per veicoli di trasporto e piu'particolarmente per aeronavi.
NZ183907A (en) Attenuated live equine herpes i (equine rhinopneumonitis) virus and vaccine
AU8599191A (en) Vaccines against equine herpesviruses and the preparation thereof
EP0507179A3 (en) Equine herpes viruses (ehv) containing foreign dna, process for their preparation and their use as vaccines
DK0553667T3 (da) Opløselig LDL-receptor, dens fremstilling og anvendelse
ITRM910669A1 (it) Cestello contenitore del filtro dell'aria per autoveicoli.
OA09653A (en) Rubella peptides
IT8120635A0 (it) Procedimento per la manipolazione di prodotti stampati, come pure mezzi e dispositivo perl'esecuzione dello stesso.
IT8009558A0 (it) Procedimento ed impianto per la liberazione da polveri cioe'depolverazione di particelle, per la depolverazione di particelledi allumina ed altro
EP0655072A4 (en) EQUINE HERPESVIRUS GLYCOPROTEINS.
ATE165620T1 (de) Impfstoffe auf basis geänderter boviner herpesviren typ 1
IT9017917A0 (it) Piastra di mimetizzazione per casstte di sicurezza da incasso.
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
ATA13190A (de) Transportwaggon, insbesondere niederflurwagen
Waldo A practical guide for dealing with AIDS at work.
DE59106398D1 (de) Oligophosphate mit antiviraler Wirkung.
MCDONALD Optical surface damage from reentrant gases on STS[Final Report]
IT1209625B (it) Metodo e mezzo per la lotta contro farfalle nocive nei vigneti.
CHI et al. Kinetic expressions of PD-L1 and PD-L2 on the surface of human lymphocytes and monocytes